BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36374927)

  • 1. Down-regulation of hepatic expression of GHR/STAT5/IGF-1 signaling pathway fosters development and aggressiveness of HCV-related hepatocellular carcinoma: Crosstalk with Snail-1 and type 2 transforming growth factor-beta receptor.
    Abu El-Makarem MA; Kamel MF; Mohamed AA; Ali HA; Mohamed MR; Mohamed AEM; El-Said AM; Ameen MG; Hassnine AA; Hassan HA
    PLoS One; 2022; 17(11):e0277266. PubMed ID: 36374927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma.
    Lin CC; Liu TW; Yeh ML; Tsai YS; Tsai PC; Huang CF; Huang JF; Chuang WL; Dai CY; Yu ML
    Clin Mol Hepatol; 2021 Apr; 27(2):313-328. PubMed ID: 33317258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of GH/IGF-1 Axis in the Liver of Patients with HCV-Related Chronic Hepatitis.
    Carotti S; Guarino MPL; Valentini F; Porzio S; Vespasiani-Gentilucci U; Perrone G; Zingariello M; Gallo P; Cicala M; Picardi A; Morini S
    Horm Metab Res; 2018 Feb; 50(2):145-151. PubMed ID: 28922679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The somatotropic axis during the physiological estrus cycle in dairy heifers--Effect on hepatic expression of GHR and SOCS2.
    Mense K; Meyerholz M; Gil Araujo M; Lietzau M; Knaack H; Wrenzycki C; Hoedemaker M; Piechotta M
    J Dairy Sci; 2015 Apr; 98(4):2409-18. PubMed ID: 25704974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone stimulates hepatic expression of bovine growth hormone receptor messenger ribonucleic acid through signal transducer and activator of transcription 5 activation of a major growth hormone receptor gene promoter.
    Jiang H; Wang Y; Wu M; Gu Z; Frank SJ; Torres-Diaz R
    Endocrinology; 2007 Jul; 148(7):3307-15. PubMed ID: 17412814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis.
    Mamiya T; Yamazaki K; Masugi Y; Mori T; Effendi K; Du W; Hibi T; Tanabe M; Ueda M; Takayama T; Sakamoto M
    Lab Invest; 2010 Sep; 90(9):1339-45. PubMed ID: 20531292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
    Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
    Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
    Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
    Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
    Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
    Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor alpha blockade restores growth hormone signaling in murine colitis.
    DiFedele LM; He J; Bonkowski EL; Han X; Held MA; Bohan A; Menon RK; Denson LA
    Gastroenterology; 2005 May; 128(5):1278-91. PubMed ID: 15887111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
    Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
    Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic growth hormone resistance during sepsis is associated with increased suppressors of cytokine signaling expression and impaired growth hormone signaling.
    Yumet G; Shumate ML; Bryant DP; Lang CH; Cooney RN
    Crit Care Med; 2006 May; 34(5):1420-7. PubMed ID: 16540952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis.
    Venken K; Schuit F; Van Lommel L; Tsukamoto K; Kopchick JJ; Coschigano K; Ohlsson C; Movérare S; Boonen S; Bouillon R; Vanderschueren D
    J Bone Miner Res; 2005 Dec; 20(12):2138-49. PubMed ID: 16294267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human GH receptor-IGF-1 receptor interaction: implications for GH signaling.
    Gan Y; Buckels A; Liu Y; Zhang Y; Paterson AJ; Jiang J; Zinn KR; Frank SJ
    Mol Endocrinol; 2014 Nov; 28(11):1841-54. PubMed ID: 25211187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic growth hormone receptor (GHR) controls hepatic glucose production in nutrient-sensing leptin receptor (LepRb) expressing neurons.
    Cady G; Landeryou T; Garratt M; Kopchick JJ; Qi N; Garcia-Galiano D; Elias CF; Myers MG; Miller RA; Sandoval DA; Sadagurski M
    Mol Metab; 2017 May; 6(5):393-405. PubMed ID: 28462074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
    Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
    Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
    Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin-like growth factor-II and alpha-fetoprotein as tumor markers of hepatocellular carcinoma.
    Tsai JF; Jeng JE; Chuang LY; You HL; Ho MS; Lai CS; Wang LY; Hsieh MY; Chen SC; Chuang WL; Lin ZY; Yu ML; Dai CY
    Tumour Biol; 2003; 24(6):291-8. PubMed ID: 15004489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.
    Gan Y; Paterson AJ; Zhang Y; Jiang J; Frank SJ
    Endocrinology; 2014 Mar; 155(3):1000-9. PubMed ID: 24302626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherent growth hormone resistance in the skeletal muscle of the fine flounder is modulated by nutritional status and is characterized by high contents of truncated GHR, impairment in the JAK2/STAT5 signaling pathway, and low IGF-I expression.
    Fuentes EN; Einarsdottir IE; Valdes JA; Alvarez M; Molina A; Björnsson BT
    Endocrinology; 2012 Jan; 153(1):283-94. PubMed ID: 22028448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.